Akcie v oběhu společnosti Suda Pharmaceuticals Ltd
Jaká je hodnota metriky Akcie v oběhu společnosti Suda Pharmaceuticals Ltd?
Hodnota metriky Akcie v oběhu společnosti Suda Pharmaceuticals Ltd je 421.155M 109.49%
Jaká je definice metriky Akcie v oběhu?
Akce v oběhu (Shares float) je podíl akcií společnosti vlastněných veřejnými investory vůči zablokovaným akcím (nejsou volně v oběhu).
Shares float represents the portion of shares of a corporation that are in the hands of public investors as opposed to locked-in stock held by promoters, company officers, controlling-interest investors, or government. This number is sometimes seen as a better way of calculating market capitalization because it provides a more accurate reflection of what public investors consider the company to be worth. In this context, the float may refer to all the shares outstanding that can be publicly traded
The float is calculated by subtracting the locked-in shares from outstanding shares. Stocks with smaller floats tend to be more volatile than those with larger floats. In general, the large holdings of founding shareholders, corporate cross-holdings, and government holdings in partially privatized companies are excluded when calculating the size of a public float.
Akcie v oběhu společností v sektoru Health Care sektor na ASX ve srovnání se společností Suda Pharmaceuticals Ltd
Čemu se věnuje společnost Suda Pharmaceuticals Ltd?
Suda Pharmaceuticals Ltd engages in the development of drug delivery technology in Australia, India, Europe and Korea. It offers ZolpiMist, an oro-mucosal spray formulation of zolpidem tartrate marketed under the brand name of Ambien or Stilnox, a non-benzodiazepine prescribed for the short-term treatment of insomnia. The company's product pipeline includes Sumatriptan, an oral spray formulation for the treatment of acute migraine; and anagrelide, a platelet lowering agent for use in thrombosis, which is used for the treatment of cancer. Suda Pharmaceuticals Ltd has license and supply agreement with Teva Pharmaceuticals International GmbH and Mitsubishi Tanabe Pharma Singapore for ZolpiMist oral spray; product development, licence, and supply agreement with Cann Pharmaceutical Australia Ltd for the development of novel oral spray of pharmaceutical-grade cannabinoid derivatives for the treatment of drug resistant epilepsy, melanoma, and motion sickness; and feasibility and option agreement with Zelira Therapeutics for the use of cannabinoids for a range of uses, including insomnia, autism, opioid reduction, anxiety, pain, and cancer. The company also has a feasibility study and option agreement with Laboratorios Ordesa, S.L. The company was formerly known as Suda Limited and changed its name to Suda Pharmaceuticals Ltd in November 2017. Suda Pharmaceuticals Ltd was incorporated in 1999 and is headquartered in Osborne Park, Australia.
Firmy s metrikou akcie v oběhu podobnou společnosti Suda Pharmaceuticals Ltd
- Hodnota metriky Akcie v oběhu společnosti Base Resources je 420.154M 35.67%
- Hodnota metriky Akcie v oběhu společnosti Intra je 420.491M 92.24%
- Hodnota metriky Akcie v oběhu společnosti IMS je 420.500M 42.05%
- Hodnota metriky Akcie v oběhu společnosti Huarchi Global je 420.580M 21.03%
- Hodnota metriky Akcie v oběhu společnosti Clean Power Capital je 420.661M 94.27%
- Hodnota metriky Akcie v oběhu společnosti AbraPlata Resource je 421.006M 91.77%
- Hodnota metriky Akcie v oběhu společnosti Suda Pharmaceuticals Ltd je 421.155M 109.49%
- Hodnota metriky Akcie v oběhu společnosti MSM International je 421.544M 50.04%
- Hodnota metriky Akcie v oběhu společnosti New World Department Store China je 421.570M 25.00%
- Hodnota metriky Akcie v oběhu společnosti Fountain Set () je 422.059M 34.45%
- Hodnota metriky Akcie v oběhu společnosti SBI Life Insurance je 422.069M 42.17%
- Hodnota metriky Akcie v oběhu společnosti Biocon je 422.508M 35.21%
- Hodnota metriky Akcie v oběhu společnosti Kier Plc je 422.684M 94.71%